New study has discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad cholesterol and triglycerides in...
Vous n'êtes pas connecté
Maroc - Times of India - Top Stories - 09/Nov 03:47
New study has discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad cholesterol and triglycerides in a single treatment. This scientific advancement offers a potential future where managing heart health may involve one-time interventions rather than daily routines. While still in early stages, this breakthrough underscores the enduring importance of everyday healthy habits for cardiovascular wellness.
New study has discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad cholesterol and triglycerides in...
Avocados are a heart-healthy superfood, packed with beneficial fats, fibre, and potassium that help manage cholesterol and blood pressure. Their rich...
CHICAGO, (Reuters) – A single infusion of CRISPR Therapeutics’ CRSP.BN experimental gene therapy was safe and reduced levels of harmful LDL...
A new pill called Enlicitide from Merck offers hope for cholesterol management. This first-ever oral PCSK9 inhibitor demonstrated substantial LDL...
Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an effective alternative to...
Worried about peanut butter's impact on your heart? Surprisingly, natural peanut butter, in moderation, can actually boost heart health. Its healthy...
Worried about peanut butter's impact on your heart? Surprisingly, natural peanut butter, in moderation, can actually boost heart health. Its healthy...
BAVINA SOOKDEO According to the International Diabetes Federation, presently, the prevalence of diabetes is between 12 to 15 per cent of our...
BAVINA SOOKDEO According to the International Diabetes Federation, presently, the prevalence of diabetes is between 12 to 15 per cent of our...
In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in...